FeesSafety
Pluang+

OTC Markets reports flat to modest gains in Q3 2026 index performances with notable growth in banks and Canadian stocks.

Market News
03 Nov 2026, 14:00 WIB
GlobeNewsWire
View Source
Neutral
OTC Markets reports flat to modest gains in Q3 2026 index performances with notable growth in banks and Canadian stocks.

OTC Markets Group announced the Q3 2026 performance and rebalancing of its OTCQX indexes. Most indexes showed flat or slight declines, including the OTCQX Composite (-0.2%), Billion+ (-0.4%), Dividend (-0.8%), and International (-0.3%) indexes. However, the OTCQX Banks Index rose 8.7%, the OTCQX Canada Index gained 10.2%, and the OTCQX U.S. Index increased 6.7%. The quarterly rebalancing included additions and removals of companies across these indexes. This update reflects market stability with pockets of growth, especially in regional banks and Canadian stocks, signaling areas of investor interest.

OTC Markets Group's quarterly index performance and rebalancing provide context for financial market activity. For readers following financials, here is Pluang's market snapshot as of Nov 03, 2026 18:42 WIB: out of 142 priced US financial stocks, 56 rose and 77 fell. Notable prices include RKT at USD 13.59 with a 1-day change of -1.31%, TRV at USD 393.85 down 1.24%, and SAN at USD 11.32 down 1.22%.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App